Ophthalmologists must embrace corneal diagnostics to select the proper patient for premium multifocal IOLs, according to a ...

LONDON and NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic ...

OK-101, a novel, non-opioid therapeutic candidate, is designed to target and alleviate the debilitating pain associated with corneal nerve damage, a condition for which there are currently no U.S ...

OK-101 demonstrated statistically significant benefit in a “sign” endpoint, namely “total conjunctival staining” as measured by the Ora Calibra Staining Scale as early as Day 29 (p = 0.034).

LONDON and NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of ...

VKC grading was based on past/present clinical signs and frequency of symptoms rather than disease activity. The electronic medical records were screened and details of VKC patients diagnosed by ...

So that'd be something like squinting, tearing, and redness to the eye. You can also start to see some redness to the cornea itself, but any of those things are going to tell you that you need you at ...

CNN reporters and hosts said Monday that President Biden's decision to pardon his family members in the waning minutes of his administration tarnished his reputation and was "a stain on his legacy." ...

To prepare F-Au NCs, 30-mL CD-Au NC solution was mixed with 300 μL fluorescein (final concentration: 300 nM). After 2 h shaking at 30°C, the mixture was filtered with a 10-KDa ultrafiltration tube ...